Tag: Investigational New Drug Application

August 22, 2019

Seelos Therapeutics Receives IND Application Approval for SLS-005

Seelos Therapeutics (NASDAQ:SEEL) has announced that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug Application...
August 14, 2019

Zosano Pharma Files IND for a Phase 2/3 Clinical Study in Cluster Headache

Zosano Pharma (NASDAQ:ZSAN) has announced it has filed an investigational new drug application to the US Food and Drug Administration...
August 12, 2019

ProQR Receives IND Clearance to Start Clinical Trial of QR-1123

ProQR Therapeutics (NASDAQ:PRQR) has announced that the US Food and Drug Administration (FDA) has cleared the company’s investigational new drug...
July 19, 2019

Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon

Ascendis Pharma (NASDAQ:ASND) has announced it has filed an investigational new drug application with the US Food and Drug Administration...
June 25, 2019

Arvinas Authorized to Proceed with ARV-471

Arvinas (NASDAQ:ARVN) has announced that the US Food and Drug Administration (FDA) has authorized the company’s investigational new drug application...
June 18, 2019

CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar

CymaBay Therapeutics (NASDAQ:CBAY) has announced that the US Food and Drug Administration (FDA) has cleared the company’s investigational new drug...
May 16, 2019

Cue Biopharma Announces FDA Acceptance of IND for Lead Immuno-oncology Candidate CUE-101

Cue Biopharma (NASDAQ:CUE) has announced that the US Food and Drug Administration (FDA) has accepted Cue Biopharma’s investigational new drug...